Orchard Therapeutics (NASDAQ: ORTX) experienced a remarkable 97% surge in its shares following a major announcement on October 5th, 2023. The renowned global gene therapy leader, Orchard, has been successfully acquired by Kyowa Kirin (OTC: KYKOF), solidifying its position as a fully owned subsidiary. The Agreement: The agreement outlines that Kyowa plans to buy all
Kyowa Kirin to Acquire Orchard Therapeutics for Up-to-$477 6M genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
-Orchard Therapeutics is a global gene therapy leader with experience successfully developing and commercializing medicines for rare diseases Acquisition enriches Kyowa Kirin’s portfolio, enables.
Orchard Therapeutics (ORTX) Acquired by Kyowa Kirin for $16/sh Cash plus $1 CVR streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Gene therapy company Orchard Therapeutics Plc (NASDAQ: ORTX) shares are trading higher after it agreed to be acquired by Kyowa Kirin Co., a Japan-based global specialty pharmaceutical company, for $16.00 per American Depositary Share (ADS) in cash